tional_tax":null,"exhibitor_link":"https://www.sponsorships.binaytara.org/OklahomaThoracic26","homepage_image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/a33d8413-d552-4709-c943-3dbe0b633600/public","additional_info":"","target_audience":"

Medical Oncologists
Surgeons
Radiation Oncologists
Pathologists
Oncology Fellows
Oncology Nurses
Nurse Practitioners
Physician Assistants
Pharmacists

","meta_description":"","calculated_credit":null,"learning_objectives":"

Upon completion of this activity, participants should be able to:

Recognize and interpret actionable molecular alterations in lung cancer to guide appropriate diagnostic testing and targeted treatment selection.
Apply updated clinical guidelines and expert consensus to develop individualized management plans for patients with NSCLC and SCLC.
Evaluate the efficacy, safety, and clinical integration of immune checkpoint inhibitors, targeted therapies, and perioperative systemic treatments in lung cancer care.
Incorporate emerging clinical data and multidisciplinary insights to refine treatment sequencing and improve patient outcomes across all stages of thoracic malignancies.

","organizing_committee":"

Conference Director:

Binay Shah, MD, MHA - Binaytara

Conference Co-Chairs:

Raid Aljumaily, MD - OU Health

Abdul Rafeh Naqash, MD - OU Health

Clay T. Reed, MD -Integris Health

","price_additional_info":null,"accreditation_additonal_info":"This activity is supported with a Independent Medical Education grant from:\nGilead"},"programData":[{"id":1768336949641,"title":"Screening & Risk: Beyond Pack-Years","start":"2026-03-07T15:30:00.000Z","end":"2026-03-07T16:00:00.000Z","description":null,"raw_faculty":[{"id":1342,"role":"session_chair","uuid":"19c89f98-8f41-41ae-b0ec-02250b61929e","conf_id":54,"faculty":{"id":1379,"bio":"Completed my residency in internal medicine at Georgetown University Hospital. Subsequently, I worked in health economics on cost measures for Medicare as well as several Advanced Alternative Payment Models including the Bundled Payment Care Incentive and review of the initial Oncology Care Model. After 4 years, I decided to go back to oncology and did my fellowship at the National Cancer Institute where my fellowship was oncology/cancer prevention. I focused on thoracic oncology as well as cancer prevention and cost of treatments. I am currently at Oklahoma University where my focus in thoracic oncology and developing a clinic for following indeterminate nodules.","dob":null,"city":"Oklahoma City","uuid":"19c89f98-8f41-41ae-b0ec-02250b61929e","email":"nirmal-choradia@ouhsc.edu","state":"OK","prefix":null,"street":"800 NE 10th St","country":"United States","zipcode":"73104","isActive":true,"latitude":null,"pronouns":null,"last_name":"Choradia","longitude":null,"time_zone":null,"work_city":null,"additional":null,"created_at":"2025-08-05T22:10:21.135592+00:00","first_name":"Nirmal","npi_number":null,"updated_at":null,"work_state":null,"abim_number":null,"customer_id":2805,"middle_name":null,"nabp_number":null,"work_street":null,"designations":[{"id":4893,"isActive":true,

Conferences

Organizing Committee:

Target Audience:

Learning Objectives: